Journal article
Phase II trial of gemcitabine and vinorelbine in patients with stage III B and IV non small cell lung cancer
Abstract
Background. Gemcitabine and vinorelbine are active agents in advanced non-small cell lung cancer. We conducted a phase II trial of this combination in untreated patients with stage III B or IV non-small cell lung cancer.Patients and methods. Treatment was administered on days 1, 8 and 15 of a 28-day cycle with vinorelbine at a dose of 17.5 mg/m2 and gemcitabine 1,000 mg/m2. Patient characteristics included: 25 patients (18 males), median age …
Authors
Chasen MR; Vorobiof DA
Journal
Clinical and Translational Oncology, Vol. 5, No. 1, pp. 21–26
Publisher
Springer Nature
Publication Date
January 2003
DOI
10.1007/bf02712837
ISSN
1699-048X